Cover image of the article: Broader use of hepatitis B virus vaccine: Efficacy in those who lost hepatitis B surface antigen during follow-up

Image Credit:Hepat Mon

Broader use of hepatitis B virus vaccine: Efficacy in those who lost hepatitis B surface antigen during follow-up

Authors

Rakesh Kumar1,*, Babita Agrawal2
1Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, rkumar@ualberta.ca, Canada
2Department of Surgery, University of Alberta, Edmonton, Canada
*Corresponding Author: Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, rkumar@ualberta.ca, Canada. Tel: +1-7804927545. Fax: +1-7804927521. Email: rkumar@ualberta.ca

Hepatitis Monthly:Vol. 11, issue 6; 477-478
Published online:Jun 30, 2011
Article type:Letter
Received:Apr 05, 2011
Accepted:Apr 08, 2011
How to Cite:Kumar R, Agrawal B. Broader use of hepatitis B virus vaccine: Efficacy in those who lost hepatitis B surface antigen during follow-up. Hepat Mon. 2011;11(6):. doi:

Abstract

This article does not have abstract.

Full Text

Full text is available in PDF

Copyright

© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

30
Apr
2011
Immune response to hepatitis B vaccine in patients who lost hepatitis B surface antigen during follow up

Immune response to hepatitis B vaccine in patients who lost hepatitis B surface antigen during follow up

Georgios Zacharakis,
Nikos Viazis,
Dimitrios Karamanolis

Zacharakis G, Viazis N, Karamanolis D. Immune response to hepatitis B vaccine in patients who lost hepatitis B surface antigen during follow up. Hepat Mon. 2011;11(6):. doi:

30
Jul
2012
Serum Hepatitis B Surface Antigen Levels and Their Utility as a Predictor of Sustained Virological Response After Antiviral Treatment

Serum Hepatitis B Surface Antigen Levels and Their Utility as a Predictor of Sustained Virological Response After Antiviral Treatment

Peter Karayiannis

Karayiannis P. Serum Hepatitis B Surface Antigen Levels and Their Utility as a Predictor of Sustained Virological Response After Antiviral Treatment. Hepat Mon. 2012;12(7):. doi: https://doi.org/10.5812/hepatmon.6201

11
Mar
2014
Hepatitis B Vaccination: Needs a Revision

Hepatitis B Vaccination: Needs a Revision

Mohammad Saeid Rezaee-Zavareh,
Behzad Einollahi

Rezaee-Zavareh MS, Einollahi B. Hepatitis B Vaccination: Needs a Revision. Hepat Mon. 2014;14(3):e17461. doi: https://doi.org/10.5812/hepatmon.17461

30
Jun
2006
Hepatitis B e Antigen-Negative Chronic Hepatitis B

Hepatitis B e Antigen-Negative Chronic Hepatitis B

Maryam Vaez Jalali,
Seyed Moayed Alavian

Jalali M, Alavian S. Hepatitis B e Antigen-Negative Chronic Hepatitis B. Hepat Mon. 2006;6(1):. doi:

31
Oct
2011
Immune Response to Hepatitis B Vaccine in Patients with Chronic Kidney Disease

Immune Response to Hepatitis B Vaccine in Patients with Chronic Kidney Disease

Behzad Einollahi

Einollahi B. Immune Response to Hepatitis B Vaccine in Patients with Chronic Kidney Disease. Hepat Mon. 2011;11(10):. doi: https://doi.org/10.5812/kowsar.1735143x.766

More by these authors

Rakesh KumarPubMedScholar
Babita AgrawalPubMedScholar
Share
Cited by
Metrics